With the new quarter starting tomorrow funds will be buying here. Company's response to the F.D.A. could be issued at anytime. News on other drugs in the pipeline will only help to bounce this higher. Chart indicates a move to the $4.25 range is likely short term and then trending upward from there. 2,000,000+ million shares short will make the next week very interesting.